SH3BGRL: A Promising Drug Target for Various Diseases (G6451)

Target Name: SH3BGRL

NCBI ID: G6451

SH3BGRL

SH3BGRL: A Promising Drug Target for Various Diseases

SH3BGRL (S-adenosyl-3-beta-glucosamine) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, and liver. It is a key regulator of cellular processes that are essential for maintaining tissue function and health.

Recent studies have identified SH3BGRL as a potential drug target (or biomarker) for a variety of diseases, including neurodegenerative disorders, diabetes, and cardiovascular disease. This is because SH3BGRL has been shown to play a role in the regulation of key cellular processes that are involved in the development and progression of these diseases.

One of the key functions of SH3BGRL is its role in the regulation of cellular signaling pathways. SH3BGRL is a protein that is involved in the regulation of several different signaling pathways, including the TGF-β pathway and the PI3K/Akt pathway. These pathways are involved in the regulation of cell growth, differentiation, and survival, and are key regulators of many diseases.

In addition to its role in signaling pathways, SH3BGRL is also involved in the regulation of cellular interactions with the extracellular matrix (ECM). The ECM is a complex system of molecules that surrounds and supports cells, and is involved in many cellular processes, including cell adhesion, migration, and invasion.

Studies have shown that SH3BGRL plays a key role in the regulation of ECM interactions with cells. This is because SH3BGRL is involved in the production of the cytoskeleton, which is the structural foundation of eukaryotic cells. The cytoskeleton is involved in the regulation of cell shape and movement, and is critical for the proper functioning of cells.

Another function of SH3BGRL is its role in the regulation of cellular processes that are involved in inflammation and immune response. SH3BGRL is involved in the regulation of the production and activation of immune cells, as well as the regulation of inflammation.

These are just a few examples of the many functions of SH3BGRL. As a protein that is involved in the regulation of multiple cellular processes, SH3BGRL is a promising drug target for a variety of diseases.

In conclusion, SH3BGRL is a protein that has been identified as a potential drug target (or biomarker) for a variety of diseases. Its functions as a regulator of cellular signaling pathways, ECM interactions, inflammation and immune response make it an attractive target for future research and development.

Protein Name: SH3 Domain Binding Glutamate Rich Protein Like

Functions: Appears to function as an adapter protein that bridges proteins together or proteins with mRNAs (PubMed:34331014). May function as a ubiquitin ligase-substrate adapter (PubMed:34331014, PubMed:34870550). Additionally, associates with translating cytoplasmic ribosomes and may promote the expression of specific mRNAs (PubMed:34331014, PubMed:34870550)

The "SH3BGRL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH3BGRL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets